Boston Scientific (BSX) EBITDA (2008 - 2026)
Boston Scientific (BSX) EBITDA from Jun 30, 2008 to Mar 31, 2026. The TTM Boston Scientific (BSX) EBITDA is $5.19B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Boston Scientific (BSX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +25.32% |
| 3 Years TTM | +21.64% |
| 5 Years TTM | +32.75% |
| 10 Years TTM | +21.27% |
| All Time TTM | +16.50% |
Annual EBITDA change of Boston Scientific (BSX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $1.45B | -70.85% |
| 2025 | $4.98B | +28.64% |
| 2024 | $3.87B | +9.41% |
| 2023 | $3.54B | +27.07% |
| 2022 | $2.79B | +21.51% |
| 2021 | $2.29B | +119.75% |
| 2020 | $1.04B | -58.76% |
| 2019 | $2.53B | +5.38% |
| 2018 | $2.40B | +12.73% |
| 2017 | $2.13B | +68.70% |
| 2016 | $1.26B | +159.67% |
| 2015 | $486M | +14.62% |
| 2014 | $424M | -47.59% |
| 2013 | $809M | -125.40% |
| 2012 | -$3.19B | -296.48% |
| 2011 | $1.62B | +39.14% |
| 2010 | $1.17B | -2041.67% |
| 2009 | -$60M | -90.64% |
| 2008 | -$641M | -170.91% |
| 2007 | $904M | N/A |
Comparison Boston Scientific (BSX) five years EBITDA CAGR with competitors
Boston Scientific (BSX) five years EBITDA CAGR is 32.75%.